Previous studies have demonstrated increased expression of PD-L1 in CSCs of multiple cancers such as non-small cell lung cancer, hepatocellular carcinoma, breast cancer, and colorectal cancer 5-10, which may partly explain more pronounced immune evasion features of the CSCs. This evidence concerns the gene CD274 and hepatocellular carcinoma.